Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM -0.56%77 EV-to-EBIT is 13.84 as of Jul. 15, 2026, which is 47% below its 10-year median of 26.22. GuruFocus rates BKK:RAM with a GF Score™ of 77/100 and a GF Value™ of ฿45.41 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 470 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks better than 58.09% on this metric.
The historical rank and industry rank for Ramkhamhaeng Hospital PCL's EV-to-EBIT or its related term are showing as below:
BKK:RAM'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.7 Med: 26.22 Max: 119.61
Current: 13.84
During the past 13 years, the highest EV-to-EBIT of Ramkhamhaeng Hospital PCL was 119.61. The lowest was 8.70. And the median was 26.22.
BKK:RAM's EV-to-EBIT is ranked better than 58.09% of 470
companies
in the Healthcare Providers & Services industry
Industry Median: 15.82
vs BKK:RAM: 13.84
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ramkhamhaeng Hospital PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿55,597 Mil.
Ramkhamhaeng Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿3,975 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramkhamhaeng Hospital PCL EV-to-EBIT Related Terms
Ramkhamhaeng Hospital PCL EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's EV-to-EBIT falls into.
Ramkhamhaeng Hospital PCL's current Enterprise Value is ฿54,997 Mil.
Ramkhamhaeng Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿3,975 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramkhamhaeng Hospital PCL (BKK:RAM) has a EV-to-EBIT of 13.84 as of Jul. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ramkhamhaeng Hospital PCL and its competitors. This is 47% below median its historical median of 26.22. Over the past decade, Ramkhamhaeng Hospital PCL's EV-to-EBIT has ranged from 8.70 to 119.61. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #197 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 41.9%.
Is Ramkhamhaeng Hospital PCL's EV-to-EBIT too high?
Ramkhamhaeng Hospital PCL's current EV-to-EBIT of 13.84 is 47% below median its 10-year median of 26.22. Over the past 10 years, this metric has ranged from a low of 8.70 to a high of 119.61. The Healthcare Providers & Services industry median EV-to-EBIT is 15.82. Ramkhamhaeng Hospital PCL's value of 13.84 is 12.5% below this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #197 out of 470 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #197 out of 470 companies for EV-to-EBIT. This puts Ramkhamhaeng Hospital PCL in the upper half of its industry. The industry median EV-to-EBIT is 15.82. Ramkhamhaeng Hospital PCL's value of 13.84 is 12.5% below this benchmark. Historically, Ramkhamhaeng Hospital PCL's own EV-to-EBIT has ranged from 8.70 to 119.61 over the past decade. While the company's 10-year median is 26.22 vs. the industry median of 15.82, Ramkhamhaeng Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.82, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current EV-to-EBIT of 13.84 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ramkhamhaeng Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current EV-to-EBIT is 13.84, which is 47% below median its own 10-year median of 26.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL (BKK:RAM) is currently considered Possible Value Trap. The stock's GF Value™ is ฿45.41, compared to a current price of ฿17.90 — trading 60.6% below its estimated fair value. The current EV-to-EBIT is 13.84, which is 47% below median its 10-year median of 26.22 and 12.5% below the Healthcare Providers & Services industry median of 15.82. Ramkhamhaeng Hospital PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM), the current EV-to-EBIT is 13.84 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.90 is trading 60.6% below its estimated GF Value™ of ฿45.41.
GuruFocus considers Ramkhamhaeng Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:RAM:
EV-to-EBIT: 13.84 (47% below median its 10-year median of 26.22)
GF Value™: ฿45.41 vs. price of ฿17.90 (60.6% below fair value)
Industry Position: 12.5% below the Healthcare Providers & Services median (#197 of 470)
No single metric tells the full story. See the BKK:RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
77GF Score
Get the complete analysis for BKK:RAM
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM has been successfully added to your 
